Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123418
Published online Jan 21, 2027. doi: 10.3748/wjg.123418
Published online Jan 21, 2027. doi: 10.3748/wjg.123418
Table 1 Comparison of clinical features and treatment patterns between patients with mild-to-moderate and moderate-to-severe ulcerative colitis
| Mild-to-moderate (n = 1674) | Moderate-to-severe (n = 208) | P value | |
| Female | 726 (43.4) | 98 (47.1) | 0.341 |
| Age at onset, years | 38.86 (28.19-50.38) | 37.26 (27.26-50.10) | 0.431 |
| Age at diagnosis, years | 39.83 (28.80-51.96) | 38.29 (28.10-52.19) | 0.629 |
| Time period of diagnosis | |||
| 1999-2014 | 468 (28.0) | 54 (26.0) | 0.600 |
| 2015-2024 | 1206 (72.0) | 154 (74.0) | |
| Disease extent at diagnosis | |||
| E1 | 433 (25.9) | 1 (0.5) | < 0.001 |
| E2 | 336 (20.1) | 29 (13.9) | |
| E3 | 429 (25.6) | 128 (61.5) | |
| Unknown | 476 (28.4) | 50 (24.0) | |
| Overall therapeutic exposure | |||
| Corticosteroids | 374 (22.3) | 206 (99.0) | < 0.001 |
| Immunomodulators | 116 (6.9) | 53 (25.5) | < 0.001 |
| AT | 469 (28.0) | 117 (56.2) | < 0.001 |
| Years to corticosteroids | 2.26 (0.88-5.52) | 0.00 (0.00-0.01) | < 0.001 |
| Years to immunomodulators | 3.07 (1.64-6.19) | 0.90 (0.07-3.09) | < 0.001 |
| Years to AT | 3.71 (1.34-7.98) | 0.92 (0.05-4.09) | < 0.001 |
| Highest grade of medical therapy | |||
| 5-ASA | 1057 (63.1) | - | < 0.001 |
| Corticosteroids | 101 (6.0) | 68 (32.7) | |
| Immunomodulator | 47 (2.8) | 23 (11.1) | |
| AT | 469 (28.0) | 117 (56.2) | |
| Type of first-line AT1 | |||
| Anti-TNF | 156 (33.3) | 64 (54.7) | < 0.001 |
| Vedolizumab | 248 (52.9) | 41 (35.0) | |
| Ustekinumab | 4 (0.9) | 0 (0.0) | |
| JAK inhibitors | 3 (0.6) | 4 (3.4) | |
| Others2 | 58 (12.4) | 8 (6.8) | |
| Efficacy of first-line AT at induction | |||
| Clinical response | 330 (70.4) | 71 (60.7) | 0.111 |
| Primary nonresponse | 113 (24.1) | 39 (33.3) | |
| Unknown | 26 (5.5) | 7 (6.0) | |
| Number of AT types | |||
| 1 | 339 (20.3) | 73 (35.1) | < 0.001 |
| ≥ 2 | 130 (7.8) | 44 (21.2) | |
| No AT | 1205 (72.0) | 91 (43.8) | |
| Colectomy | 101 (6.0) | 52 (25.0) | < 0.001 |
- Citation: Yang WJ, Yao LY, Cao YS, Xia WH, Cao XH, Xu YN, Miao YJ, Cao Q. Long-term treatment trajectories and surgical outcomes in Chinese patients with ulcerative colitis. World J Gastroenterol 2027; 33(3): 123418
- URL: https://www.wjgnet.com/1007-9327/full/v33/i3/123418.htm
- DOI: https://dx.doi.org/10.3748/wjg.123418